Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytes.
暂无分享,去创建一个
Craig W. Reynolds | Y. Chiang | P. Tiberghien | C. Ferrand | P. Hervé | J. Cahn | J. Certoux | E. Contassot | W. Jacob
[1] D. Longo,et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study. , 1997, Human gene therapy.
[2] Craig W. Reynolds,et al. Gene transfer applied to the modulation of alloreactivity. , 1996, Hematology and cell therapy.
[3] P. Pileri,et al. Antigen-independent activation of naive and memory resting T cells by a cytokine combination , 1994, The Journal of experimental medicine.
[4] Craig W. Reynolds,et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? , 1994, Blood.
[5] P. Tiberghien. Use of suicide genes in gene therapy , 1994, Journal of leukocyte biology.
[6] Z. Ram,et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.
[7] A. Rimm,et al. T-cell depletion of HLA-identical transplants in leukemia. , 1991, Blood.
[8] A. Fischer,et al. SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI‐INTERLEUKIN-2 RECEPTOR B CHAIN‐SPECIFIC IMMUNOTOXIN , 1990, Transplantation.
[9] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[10] H. Balfour,et al. Human pharmacokinetics of the antiviral drug DHPG , 1986, Clinical pharmacology and therapeutics.
[11] W F Anderson,et al. Improved methods of retroviral vector transduction and production for gene therapy. , 1994, Human gene therapy.
[12] A. Fischer,et al. Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. , 1994, Blood.